期刊文献+

重组人血管内皮抑制素注射液对宫颈癌裸鼠移植瘤生长转移及血管淋巴管生成的抑制作用 被引量:9

Endostar reduces the growth and metastasis by inhibiting angiogenesis and lymphangiogenesis in nude mouse models of human cervical cancer
原文传递
导出
摘要 目的观察重组人血管内皮抑制素注射液(商品名恩度^R)对宫颈癌裸鼠移植瘤生长、转移及血管、淋巴管生成的抑制作用。方法以人宫颈癌HeLa细胞株接种BALB/c—nu雌性裸鼠,建立动物模型。随机将裸鼠分为对照组、顺铂组、恩度组、小剂量恩度(10mg/kg)+顺铂组和大剂量恩度(20mg/kg)+顺铂组等5组,观察肿瘤生长和淋巴结转移情况。采用免疫组织化学法检测移植瘤的微血管密度(MVD)和微淋巴管密度(MLD)。结果大剂量恩度+顺铂组、小剂量恩度+顺铂组和恩度组的肿瘤生长速度明显慢于对照组和顺铂组(P〈0.05)。大剂量恩度+顺铂组、小剂量恩度+顺铂组、恩度组、顺铂组和对照组的裸鼠肿瘤淋巴结转移率分别为0(0/8)、12.5%(1/8)、12.5%(1/8)、62.5%(5/8)、75.0%(6/8,P=0.002)。大剂量恩度+顺铂组、小剂量恩度+顺铂组、恩度组、顺铂组和对照组的裸鼠肿瘤MVD分别为10.88±1.38、10.25±1.22、10.83±2.29、15.58±2.31和22.08±1.93(P=0.000),MLD分别为5.00±0.63、5.17±0.75、6.00±0.63、14.33±1.63和13.67±1.21(P=0.000)。结论恩度可以通过抑制裸鼠宫颈癌模型的血管和淋巴管生成,而抑制肿瘤的生长和淋巴结转移。 Objective To observe the influence of endostar alone or in combination with cisplatin on tumor growth and metastasis, as well as the inhibition of angiogenesis and lymphangiogenesis in nude mouse models of human cervical cancer. Methods HeLa cells were inoculated subcutaneously into the hind flank region of female nu/mice to establish xenograft models. The nude mice were randomly divided into 5 groups : ( 1 ) sodium chloride ( as control ) ; ( 2 ) cisplatin alone ; ( 3 ) endostar alone ; ( 4 ) cisplatin plus endostar (10 mg/kg) ; (5) cisplatin plus endostar (20 mg/kg). The course of all the treatments lasted for 4 weeks. The tumor growth and lymph node metastasis were observed. Immunohistochemical staining was employed to detect the angiogenesis and lymphangiogenesis. Results (1) Either eudostar alone or endostar with cisplatin inhibited the tumor growth significantly than cisplatin and NS ( P 〈 0.05 ). (2) The rates of lymph node metastasis in the endostar(20 mg/kg)with cisplatin, the endostar( 10 mg/kg)with cisplatin, the endostar, the cisplatin and the NS groups were 0 ( 0/8 ), 12.5 % ( 1/8 ) , 12.5 % ( 1/8 ), 62.5 % ( 5/8 ) and 75.0% (6/8) ( P = 0. 002 ), respectively. ( 3 ) The MVD of tumor tissue in these five groups were 10.88 + 1.38, 10.25 ± 1.22, 10.83± 2.29, 15.58 ± 2.31 and 22.08± 1.93, respectively( P 〈 0.05 ). The MLD were 5.00 ±0.63, 5.17 +0.75, 6.00±0.63, 14.33 ± 1.63 and 13.67 ± 1.21, respectively (P 〈 0.05). Conclusion Endostar can reduce the tumor growth and metastasis by inhibiting angiogenesis and lymphangiogenesis in nude mouse model of human cervical cancer.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2009年第4期254-257,共4页 Chinese Journal of Oncology
基金 基金项目:河北省博士基金(05547008D-3)
关键词 宫颈肿瘤 淋巴管生成 人血管内皮抑制素注射液 裸鼠 Uterine cervical neoplasms Lymphangiogenesis
  • 相关文献

参考文献9

  • 1孙建衡.子宫颈癌治疗的回顾与展望[J].中华肿瘤杂志,2006,28(2):159-160. 被引量:21
  • 2Triratanachat S, Niruthisard S, Trivijitsilp P, et al. Angiogenesis in cervical intraepithelial neoplasia and early-staged uterine cervical squamous cell carcinoma: clinical significance. Int J Gynecol Cancer, 2006, 16:575-580.
  • 3Longatto-Filho A, Pinheiro C, Pereira SM, et al. Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-invasive and invasive lesions of the uterine cervix. Gynecol Oncol, 2007, 107 : 45-51.
  • 4杨林,王金万,孙燕,朱允中,刘晓晴,李维廉,邸立军,李佩文,王友良,宋恕平,姚晨,游丽芬.重组人血管内皮抑制素YH-16治疗晚期非小细胞肺癌的临床研究[J].中华肿瘤杂志,2006,28(2):138-141. 被引量:144
  • 5Jenkins DE, Yu SF, Homing YS, et al. In vivo monitoring of tumor relapse and metastasis using biolnminescent PC-3M-luc-C6 cells in murine modles of human prostate cancer. Clinil Exp Metastasis, 2003, 20:745-756.
  • 6荣国强,陶锋,吴浩荣.内皮抑素、阿霉素联合使用对左肝叶切除小鼠原位移植性肝癌抑制作用的实验研究[J].中国现代医药杂志,2006,8(11):36-38. 被引量:1
  • 7Shao X J, Xie FM. hffluence of angiogenesis inhibitors, endostatin and PF-4, on lymphangiogenesis. Lymphology, 2005, 38:1-8.
  • 8Fukumoto S, Morifuji M, Katakura Y, et al. Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells. Clin Expl Metastasis, 2005, 22:31-38.
  • 9Brideau G, Makinen MJ, Elamaa H, et al. Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. Cancer Res, 2007, 67 : 11528-11535.

二级参考文献14

  • 1杨林,王金万,汤仲明,刘秀文,黄镜,李树婷,董英,张和平,薛岚,储大同,孙燕.重组人血管内皮抑制素Ⅰ期临床研究[J].中国新药杂志,2004,13(6):548-553. 被引量:154
  • 2[1]Gunter Schuch,Oliver Kisker,Anthony Atala,et al.Pancreatic tumor growth regulated by the balance between positive and negative modulators of angiogenesis.Angiogenesis,2002,5:181-190
  • 3[2]Thompson CB.Apoptosis in the pathogenesis and treatment of disease.Science,1995,267:1456-1462
  • 4[3]M.Li,X.Huang,Z.Zhu,et al.The therapeutic efficacy of angio statin against weakly and high-immunogenic 3LL tumors.Invivo 2002,16:577-582
  • 5[4]M.Li,X.Huang,Z.Zhu,et al.Immunere sponse against 3LL lewis lung carcinoma potentiates the therapeutic efficacy of endostatin.J.Immunother,2001,24:472-481
  • 6[5]E.A.Tevelde,J.M.VOgten,M.F.Gebbink,et al.Enhanced antimmour efficacy by combining conventional chemotherapy with an giostatin or endostatin in a liver metastasis model.Br.J.Surg,89 2002,89:1302-1309
  • 7[6]Wolf Dietrich Beecken,Tobias Engl,Roman Blaheta,et al.Angio genesis inhibition by angiostatin,endoatatin and TNP-470 prevents cyclophosphamide induced cystitis.Angiogenesis,2004,769-73
  • 8[7]F.P.K.Wu,K.Hoekman,S.Meijer,et al.VEGF and endostatin lev els in wound fluid and plasma after breast surgery.Angiogenesis,2003,6:255-257
  • 9[8]Pingsheng Wu,Hideto Yonekura,Hui Ii,et al.Biochemical and Biophysical Research Communications,2001,288:1149-1154
  • 10Kulke M, Bergsland E, Ryan DP, et al. A phase Ⅱ, open-label,safety, pharmacokinetic, and efficacy study of recombinant human endostatin in patients with advanced neuroendocrine tumors. Proc Am Soc Clin Oncol, 2003, 22: 239.

共引文献163

同被引文献78

引证文献9

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部